LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down - Should You Sell?

LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $100.69, but opened at $91.12. LeMaitre Vascular shares last traded at $92.96, with a volume of 68,968 shares.

Analyst Upgrades and Downgrades

Several research firms have weighed in on LMAT. Oppenheimer reiterated an "outperform" rating and set a $93.00 price objective (up previously from $90.00) on shares of LeMaitre Vascular in a research report on Friday, November 1st. JMP Securities lifted their price objective on shares of LeMaitre Vascular from $77.00 to $100.00 and gave the stock a "market outperform" rating in a research note on Tuesday, August 20th. Barrington Research increased their target price on shares of LeMaitre Vascular from $92.00 to $93.00 and gave the stock an "outperform" rating in a research report on Friday, November 1st. StockNews.com cut LeMaitre Vascular from a "buy" rating to a "hold" rating in a research note on Friday. Finally, Cantor Fitzgerald started coverage on LeMaitre Vascular in a research note on Tuesday, October 15th. They set a "neutral" rating and a $96.00 price objective on the stock. Three research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $94.57.

LeMaitre Vascular Trading Down 8.5 %

The stock's fifty day moving average price is $97.65 and its two-hundred day moving average price is $89.62. The stock has a market capitalization of $2.07 billion, a P/E ratio of 51.20, a price-to-earnings-growth ratio of 2.47 and a beta of 0.93.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last announced its earnings results on Thursday, October 31st. The medical instruments supplier reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.44 by $0.05. LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.15%. The firm had revenue of $54.82 million for the quarter, compared to analysts' expectations of $53.50 million. During the same quarter in the previous year, the business posted $0.33 EPS. The company's quarterly revenue was up 15.6% on a year-over-year basis. As a group, analysts expect that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current fiscal year.

LeMaitre Vascular Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 5th. Shareholders of record on Thursday, November 21st were paid a $0.16 dividend. The ex-dividend date was Thursday, November 21st. This represents a $0.64 annualized dividend and a yield of 0.69%. LeMaitre Vascular's payout ratio is 34.97%.

Insider Buying and Selling

In other news, Director Bridget A. Ross sold 3,750 shares of the stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $101.47, for a total transaction of $380,512.50. Following the transaction, the director now directly owns 2,278 shares in the company, valued at approximately $231,148.66. This trade represents a 62.21 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 10.79% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. NBC Securities Inc. lifted its stake in LeMaitre Vascular by 73.2% during the 3rd quarter. NBC Securities Inc. now owns 433 shares of the medical instruments supplier's stock worth $40,000 after acquiring an additional 183 shares in the last quarter. USA Financial Formulas purchased a new position in LeMaitre Vascular in the third quarter valued at about $60,000. West Oak Capital LLC acquired a new stake in LeMaitre Vascular in the 2nd quarter valued at about $58,000. GAMMA Investing LLC raised its holdings in shares of LeMaitre Vascular by 34.3% in the third quarter. GAMMA Investing LLC now owns 736 shares of the medical instruments supplier's stock worth $68,000 after acquiring an additional 188 shares during the last quarter. Finally, nVerses Capital LLC raised its position in shares of LeMaitre Vascular by 33.3% in the second quarter. nVerses Capital LLC now owns 800 shares of the medical instruments supplier's stock valued at $66,000 after buying an additional 200 shares during the last quarter. 84.64% of the stock is currently owned by hedge funds and other institutional investors.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.